Lorazepam vs Diazepam for Pediatric Status Epilepticus | Zendy

James M. Chamberlain | Zendy; Pamela J. Okada | Zendy; Maija Holsti | Zendy; Prashant Mahajan | Zendy; Kathleen Brown | Zendy; Cheryl Vance | Zendy; Víctor M. González | Zendy; Richard Lichenstein | Zendy; Rachel Stanley | Zendy; David C. Brousseau | Zendy; Joseph A. Grubenhoff | Zendy; Roger Zemek | Zendy; David W. Johnson | Zendy; Traci E. Clemons | Zendy; Jill M. Baren | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lorazepam vs Diazepam for Pediatric Status Epilepticus

Author(s) -

James M. Chamberlain,

Pamela J. Okada,

Maija Holsti,

Prashant Mahajan,

Kathleen Brown,

Cheryl Vance,

Víctor M. González,

Richard Lichenstein,

Rachel Stanley,

David C. Brousseau,

Joseph A. Grubenhoff,

Roger Zemek,

David W. Johnson,

Traci E. Clemons,

Jill M. Baren

Publication year - 2014

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2014.2625

Subject(s) - lorazepam , medicine , status epilepticus , diazepam , anesthesia , sedation , randomized controlled trial , benzodiazepine , epilepsy , psychiatry , receptor

Benzodiazepines are considered first-line therapy for pediatric status epilepticus. Some studies suggest that lorazepam may be more effective or safer than diazepam, but lorazepam is not Food and Drug Administration approved for this indication.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research